Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 163133-43-5, Nitronaproxen, Naproxen-n-butyl nitrate, Hct 3012, Azd3582, No-naproxen
Molecular Formula
C18H21NO6
Molecular Weight
347.4  g/mol
InChI Key
AKFJWRDCWYYTIG-ZDUSSCGKSA-N
FDA UNII
V24GR4LI3I

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-nitrooxybutyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate
2.1.2 InChI
InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1
2.1.3 InChI Key
AKFJWRDCWYYTIG-ZDUSSCGKSA-N
2.1.4 Canonical SMILES
CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCCCCO[N+](=O)[O-]
2.1.5 Isomeric SMILES
C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCCCCO[N+](=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
V24GR4LI3I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-(nitrooxy)butyl-(2s)-2-(6-methoxy-2-naphthyl)propanoate

2. Azd 3582

3. Azd-3582

4. Azd3582

5. Naproxen-n-butyl Nitrate

6. Nicox

7. Nitric Oxide Naproxen

8. Nitric Oxide-releasing Naproxen

9. No-naproxen

2.3.2 Depositor-Supplied Synonyms

1. 163133-43-5

2. Nitronaproxen

3. Naproxen-n-butyl Nitrate

4. Hct 3012

5. Azd3582

6. No-naproxen

7. Azd-3582

8. Hct-3012

9. Ar-p900758xx

10. Azd 3582

11. V24gr4li3i

12. Chebi:76254

13. (s)-2-(6-methoxy-2-naphthyl)propanoic Acid 4-nitrooxybutyl Ester

14. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl Ester, (alphas)-

15. 4-nitrooxybutyl (2s)-2-(6-methoxynaphthalen-2-yl)propanoate

16. 4-(nitrooxy)butyl (2s)-2-(6-methoxynaphthalen-2-yl)propanoate

17. 4-(nitrooxy)butyl (s)-2-(6-methoxynaphthalen-2-yl)propanoate

18. 4-(nitrooxy)butyl (2s)-2-(6-methoxy-2-naphthyl)propanoate

19. Naproxcinod [usan]

20. Naproxcinod [usan:inn]

21. Unii-v24gr4li3i

22. Naproxcinodum

23. Naproxcinod [mi]

24. Naproxcinod [inn]

25. Naproxcinod (usan/inn)

26. Naproxen Nitroxybutyl Ester

27. Naproxcinod [who-dd]

28. Gtpl9551

29. Schembl1170879

30. Chembl2103831

31. Dtxsid20167523

32. Zinc1541804

33. Akos015914063

34. Db06682

35. Me-0138

36. Zd-3582

37. Ac-23946

38. Hy-14931

39. Cs-0003642

40. D09568

41. E87348

42. Q3335996

43. 4-(nitrooxy)butyl(2s)-2-(6-methoxy-2-naphthyl)propanoate

44. 4-(nitrooxy)butyl-(2s)-2-(6-methoxy-2 Naphthyl)propanoate

45. (s)-2-(6-methoxy-2-naphtyl) Propionic Acid 4-nitrooxybutyl Ester

46. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl Ester, (s)-

47. 2-naphthaleneacetic Acid, 6-methoxy-.alpha.-methyl-, 4-(nitrooxy)butyl Ester, (.alpha.s)-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 347.4 g/mol
Molecular Formula C18H21NO6
XLogP34.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass347.13688739 g/mol
Monoisotopic Mass347.13688739 g/mol
Topological Polar Surface Area90.6 Ų
Heavy Atom Count25
Formal Charge0
Complexity438
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.


Primary osteoarthritis


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Nitric Oxide Donors

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)


5.2 ATC Code

M - Musculo-skeletal system

M01 - Antiinflammatory and antirheumatic products

M01A - Antiinflammatory and antirheumatic products, non-steroids

M01AE - Propionic acid derivatives

M01AE18 - Naproxcinod